Browse by category

BioAge axes STRIDES trial evaluating azelaprag in combination with tirzepatide for the treatment of obesity

BioAge Labs is to discontinue the ongoing STRIDES Phase 2 study of its investigational drug candidate azelaprag as monotherapy and in...

Reduced complication-related costs and enhanced patient recovery using the Ezisurg Endostapler

15 hours ago

Fractyl unveils promising preclinical data demonstrating safety and feasibility of local delivery of RJVA-001 Rejuva Smart GLP-1 Pancreatic Gene Therapy

4 days ago

Researchers to develop BIOSYNC wireless bioelectronic device to treat obesity and diabetes

5 days ago

Browse by category

Browse by tag

Weekly Digest

Get a round-up of the main headlines from Bariatric News, directly to your inbox each week.

Get in touch!
Email: info@bariatricnews.net